OFEGE PHARM LTDActive

Company number 09689398Private limited companyIncorporated 2015
⚠ Confirmation statement overdue. It was due on 29 Jul 2026.

Key figures

£1+0.0%
Net assets 2024/25
-24.0%
Average annual change 2019/20–2024/25
01232019/202020/212021/222022/232024/25

Like most small UK companies, OFEGE PHARM LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01232019/202020/212021/222022/23puudub2023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Turnover14,00013,10024,38837,047—
Profit for the year14,00010,70018,24117,187—
Cash at bank and in hand01——1
Total assets22——1
Total liabilities01———
Net assets / total equity211—1
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

Provision of Healthcare and Pharmaceutical Services.

As described in the company's latest filed accounts.

Summary: OFEGE PHARM LTD

Company

OFEGE PHARM LTD is a private limited company registered with Companies House under company number 09689398. It was incorporated on 16 Jul 2015. Its status is active. The registered office is in Redditch (B98). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460), other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files small company accounts (filleted). Net assets were £1. Cash at bank and in hand was £1. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 29 Jul 2026.